Marijuana Use Associations with Pulmonary Symptoms and Function in Tobacco Smokers Enrolled in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).

Background: Marijuana is often smoked via a filterless cigarette and contains similar chemical makeup as smoked tobacco. There are few publications describing usage patterns and respiratory risks in older adults or in those with chronic obstructive pulmonary disease (COPD). Methods: A cross-sectional analysis of current and former tobacco smokers from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) study assessed associations between marijuana use and pulmonary outcomes. Marijuana use was defined as never, former (use over 30 days ago), or current (use within 30 days). Respiratory health was assessed using quantitative high-resolution computed tomography (HRCT) scans, pulmonary function tests and questionnaire responses about respiratory symptoms. Results: Of the total 2304 participants, 1130 (49%) never, 982 (43%) former, and 192 (8%) current marijuana users were included. Neither current nor former marijuana use was associated with increased odds of wheeze (odds ratio [OR] 0.87, OR 0.97), cough (OR 1.22; OR 0.93) or chronic bronchitis (OR 0.87; OR 1.00) when compared to never users. Current and former marijuana users had lower quantitative emphysema (P=0.004, P=0.03), higher percent predicted forced expiratory volume in 1 second (FEV1%) (P<0.001, P<0.001), and percent predicted forced vital capacity (FVC%) (p<0.001, P<0.001). Current marijuana users exhibited higher total tissue volume (P=0.003) while former users had higher air trapping (P<0.001) when compared to never marijuana users. Conclusions: Marijuana use was found to have little to no association with poor pulmonary health in older current and former tobacco smokers after adjusting for covariates. Higher forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) was observed among current marijuana users. However, higher joint years was associated with more chronic bronchitis symptoms (e.g., wheeze), and this study cannot determine if long-term heavy marijuana smoking in the absence of tobacco smoking is associated with lung symptoms, airflow obstruction, or emphysema, particularly in those who have never smoked tobacco cigarettes.

[1]  David Couper,et al.  SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. , 2016, American journal of respiratory and critical care medicine.

[2]  Jeesun Jung,et al.  Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. , 2015, JAMA psychiatry.

[3]  K. O’grady,et al.  Marijuana use trajectories during college predict health outcomes nine years post-matriculation. , 2015, Drug and alcohol dependence.

[4]  D. Tashkin,et al.  Acute Effects of Smoked Marijuana and Oral Δ9-Tetrahydrocannabinol on Specific Airway Conductance in Asthmatic Subjects1–3 , 2015 .

[5]  V. Clark,et al.  Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. , 2015, The American review of respiratory disease.

[6]  G. Martin,et al.  The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. , 2015, Annals of the American Thoracic Society.

[7]  Edwin K Silverman,et al.  Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene , 2014, Respiratory Research.

[8]  A. Fiorelli,et al.  Does cannabis smoking predispose to lung bulla formation? , 2014, Asian cardiovascular & thoracic annals.

[9]  Lisa M LaVange,et al.  Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.

[10]  D. Tashkin.  Effects of marijuana smoking on the lung. , 2013, Annals of the American Thoracic Society.

[11]  Andrew Williams,et al.  A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. , 2013, Toxicology.

[12]  M. Pletcher,et al.  Association between marijuana exposure and pulmonary function over 20 years. , 2012, JAMA.

[13]  J. Soriano,et al.  Incidental findings from lung CT scans: Implications for research , 2011, Journal of Medical Imaging and Radiation Oncology.

[14]  A. Caspi,et al.  Effects of cannabis on lung function: a population-based cohort study , 2010, European Respiratory Journal.

[15]  W. Vollmer,et al.  Marijuana and chronic obstructive lung disease: a population-based study , 2009, Canadian Medical Association Journal.

[16]  M. Weatherall,et al.  Effects of cannabis on pulmonary structure, function and symptoms , 2007, Thorax.

[17]  J. Concato,et al.  Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. , 2007, Archives of internal medicine.

[18]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[19]  M. Roth,et al.  Respiratory and Immunologic Consequences of Marijuana Smoking , 2002, Journal of clinical pharmacology.

[20]  R. White,et al.  Lung bullae and marijuana , 2002, Thorax.

[21]  D. Tashkin.  Airway effects of marijuana, cocaine, and other inhaled illicit agents , 2001, Current opinion in pulmonary medicine.

[22]  T. Moffitt,et al.  The respiratory effects of cannabis dependence in young adults. , 2000, Addiction.

[23]  M. Lebowitz,et al.  Respiratory effects of non-tobacco cigarettes: a longitudinal study in general population. , 1991, International journal of epidemiology.

[24]  J. Rose,et al.  Pulmonary hazards of smoking marijuana as compared with tobacco. , 1988, The New England journal of medicine.

[25]  E. Augustson,et al.  Respiratory effects of marijuana and tobacco use in a U.S. sample , 2007, Journal of General Internal Medicine.

[26]  D. Tashkin,et al.  Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. , 1974, The American review of respiratory disease.